CliffBio
small molecule

METAPROTERENOL SULFATE

METAPROTERENOL SULFATE

Loss of exclusivity—loss of exclusivity
CompanyMYLAN SPECIALTY LP

Drug detail

Brand nameMETAPROTERENOL SULFATE
Active ingredientMETAPROTERENOL SULFATE
Strength0.4%
Dosage formSOLUTION
RouteINHALATION
ModalitySmall molecule
FDA approvalAugust 1988
Marketing statusDISCN

More from MYLAN SPECIALTY LP

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

METAPROTERENOL SULFATE patent cliff — loss of exclusivity — | CliffBio